Business Context and Reporting Period
This Form 8-K Current Report was filed by Insperity, Inc. on December 16, 2020. The filing reports a corporate governance event regarding the appointment of a new member to the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Board Appointment: Effective December 16, 2020, the Board appointed Dr. Eli Jones as a Class III director.
- Term: Dr. Jones's initial term expires at the 2022 annual meeting of stockholders.
- Board Size: The total number of directors was set at 10.
- Committee Assignments: Dr. Jones has not been assigned to any Board committees at this time.
Compensation and Outlook
Compensation: In connection with his appointment, Dr. Jones received a pro rata share of the $150,000 Annual Director Award granted to non-employee directors. His annual compensation and retainer fees will align with those of other non-employee directors.
Outlook and Risks: The filing contains no management commentary on business outlook, risks, contingencies, or unusual items. No related party transactions requiring disclosure under Item 404(a) of Regulation S-K were reported.
Key Facts for Investor Verification
- Verify the effective date of Dr. Eli Jones's appointment (December 16, 2020).
- Confirm the updated Board size of 10 directors.
- Review the attached press release (Exhibit 99.1) for additional biographical details on Dr. Jones.
- Note that no financial results or strategic guidance are included in this specific filing.